Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Should Labcorp’s Expanded Illumina Oncology Partnership Reshape the Precision Medicine Story for LH Investors?
Labcorp and Illumina have expanded their precision oncology partnership to enhance access to next-generation sequencing-based cancer tests, including co-commercializing both tissue and liquid biopsy options. This collaboration aims to support drugmakers and strengthen payer coverage for comprehensive genomic profiling. While the partnership reinforces Labcorp’s oncology testing franchise, investors are cautioned that it may not significantly alter short-term financial sensitivities to reimbursement shifts or broader economic headwinds.